Try our Advanced Search for more refined results
Elorac, Inc. v. Sanofi-Aventis Canada Inc.
Case Number:
1:14-cv-01859
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
September 24, 2018
Sanofi Allowed To Scrap Pain Cream Contract, Judge Says
An Illinois federal judge on Monday pared a $20 million lawsuit accusing Sanofi-Aventis Canada Inc. of failing to market and sell Elorac Inc.'s cream to treat osteoarthritis, rejecting claims that Sanofi breached the parties' contract by terminating it prematurely, but also refusing to let the company off the hook for allegedly miscalculating the royalties it owed.
-
December 09, 2016
Sanofi Can't Enforce Deal It Broke In $20M Suit, Elorac Says
The maker of a cream used to treat osteoarthritis hit back at Sanofi-Aventis Canada Inc.’s claims its contract to market the cream is void, arguing Thursday that it was Sanofi who first breached the agreement at the heart of an ongoing lawsuit between the companies.
-
March 17, 2014
Sanofi Hit With $20M Suit Over Osteoarthritis Cream
Elorac Inc. hit Sanofi-Aventis Canada Inc. with a $20 million breach of contract lawsuit in Illinois federal court on Monday, accusing Sanofi of failing to successfully commercialize a Civamide topical cream used to treat osteoarthritis, despite an obligation to do so in good faith.